Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Publication year range
3.
An Esp Pediatr ; 20(9): 876-84, 1984 Jun.
Article in Spanish | MEDLINE | ID: mdl-6486581

ABSTRACT

Six cases of children between 20 months and 6 years old, who suffer Kawasaki disease are presented. All of them had diagnostic parameters required by the Investigation Committee of this disease, with similar clinical symptoms as in other countries but with an upper average age (3 years old) to Japanese patients and nearer to that of the North American patients. It is important to emphasize the appearance of exanthema in one case, as well as a multiforme erythema exudative, a rare fact, and the observation, up to now not shown, of a positive rheumatoid factor in another two of the patients. All have undergone a good evolution without cardiovascular complications.


Subject(s)
Mucocutaneous Lymph Node Syndrome/diagnosis , Child , Child, Preschool , Erythema Multiforme/etiology , Exanthema/etiology , Female , Humans , Infant , Male , Mucocutaneous Lymph Node Syndrome/complications , Spain
4.
An Esp Pediatr ; 20(9): 918, 1984 Jun.
Article in Spanish | MEDLINE | ID: mdl-6486589
5.
Chemotherapy ; 23 Suppl 1: 416-22, 1977.
Article in English | MEDLINE | ID: mdl-318977

ABSTRACT

The clinical and bacteriological response of 38 treatments performed on 24 children (11 of them neonates) carrying out separate treatments with carbenicillin (2 treatments), gentamicin [4], fosfomycin [6], and associated treatments with gentamicin plus carbenicillin [6], fosfomycin plus gentamicin [18] and fosfomycin plus carbenicillin [2] are considered. The clinical cure was obtained in 21 children (87.5%). The most effective treatment was fosfomycin plus gentamicin; both antibiotics showed synergism in vitro on isolated Serratia strains. A dosage of 75 mg/kg fosfomycin enables serum levels of about 32 mug/ml during 4-5 h, being this level higher to the MIC of all isolated strains of S. marcescens.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Enterobacteriaceae Infections/drug therapy , Fosfomycin/therapeutic use , Sepsis/drug therapy , Carbenicillin/therapeutic use , Drug Evaluation , Drug Therapy, Combination , Enterobacteriaceae Infections/microbiology , Female , Fosfomycin/blood , Gentamicins/therapeutic use , Humans , Infant , Infant, Newborn , Male , Microbial Sensitivity Tests , Sepsis/blood , Sepsis/microbiology , Serratia marcescens/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...